Business Context and Reporting Period
This Form 8-K was filed by Conversion Labs, Inc. (not Lifemd, Inc.) on May 21, 2020, reporting events occurring between May 21, 2020, and May 27, 2020. The company is a Delaware corporation headquartered in New York, NY.
Key Financial Metrics
- Debt Issuance: The company issued convertible promissory notes with an aggregate principal amount of $1,000,000.
- Cash Proceeds: Gross proceeds received from the issuance were $1,000,000.
- Interest Rate: The notes carry an interest rate of 12% upon maturity.
- Maturity: The notes are due six months from the date of issuance.
- Equity Issuance: The company issued 665,000 shares of restricted common stock as an inducement to investors.
- Conversion Price: Notes are convertible into common stock at $0.50 per share, subject to adjustment.
Material Changes
The filing reports a material definitive agreement involving the entry into debt financing and the unregistered sale of equity securities. This represents a new direct financial obligation and an increase in the company's outstanding debt and equity count compared to the prior period.
Outlook, Risks, and Contingencies
- Default Penalty: In the event of a default, the outstanding balance of the notes increases to 130% of the principal and becomes immediately due and payable.
- Regulatory Exemption: The securities were issued in reliance on Section 4(a)(2) of the Securities Act, citing a private transaction with accredited investors.
- Management Commentary: The filing contains no forward-looking guidance or management commentary regarding future operations beyond the terms of the notes.
Investor Verification Checklist
- Verify the discrepancy between the requested company name (Lifemd, Inc.) and the filing registrant (Conversion Labs, Inc.).
- Confirm the total outstanding debt load post-issuance, as this filing adds $1,000,000 in principal.
- Review the full text of the Convertible Redeemable Promissory Note (Exhibit 4.1) for specific adjustment mechanisms to the $0.50 conversion price.
- Assess the dilution impact of the 665,000 restricted shares issued as an inducement.
- Monitor the company's liquidity position to ensure it can meet the 12% interest and principal repayment obligations within six months to avoid the 130% default penalty.